Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
…, Q Lin, X Xi, J Peng, M Xu, D Chen, X Lu, R Wang… - The Lancet, 2016 - thelancet.com
Background Outcomes are poor for patients with recurrent or metastatic nasopharyngeal
carcinoma and no well established first-line chemotherapy is available for the disease. We …
carcinoma and no well established first-line chemotherapy is available for the disease. We …
Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study
F Wu, R Wang, H Lu, B Wei, G Feng, G Li, M Liu… - Radiotherapy and …, 2014 - Elsevier
Background and purpose To evaluate long-term outcome in locoregionally advanced
nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy (IMRT) and …
nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy (IMRT) and …
[HTML][HTML] Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as first-line therapy for recurrent or metastatic nasopharyngeal carcinoma: final overall survival …
…, Q Lin, X Xi, M Xu, D Chen, X Lu, R Wang… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
METHODS From February 2012 to October 2015, 362 patients were randomly assigned to
receive either GP (gemcitabine 1 g/m 2 once daily on days 1 and 8 and cisplatin 80 mg/m 2 …
receive either GP (gemcitabine 1 g/m 2 once daily on days 1 and 8 and cisplatin 80 mg/m 2 …
[HTML][HTML] Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA
M Kang, B Tang, J Li, Z Zhou, K Liu, R Wang, Z Jiang… - Molecular cancer, 2020 - Springer
Background Very few proteins encoded by the presumed non-coding RNA transcripts have
been identified. Their cellular functions remain largely unknown. This study identifies the …
been identified. Their cellular functions remain largely unknown. This study identifies the …
[HTML][HTML] Symmetry energy investigation with pion production from Sn+ Sn systems
…, T Murakami, CY Tsang, MB Tsang, R Wang… - Physics Letters B, 2021 - Elsevier
In the past two decades, pions created in the high density regions of heavy ion collisions
have been predicted to be sensitive at high densities to the symmetry energy term in the …
have been predicted to be sensitive at high densities to the symmetry energy term in the …
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
…, RS Wang, RZ Wang, XS Wang, Y Wang… - Cancer …, 2021 - Wiley Online Library
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the
nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these …
nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these …
[HTML][HTML] miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression
M Kang, Y Li, W Liu, R Wang… - International …, 2013 - spandidos-publications.com
We report the emerging role of microRNA (miRNA) deregulation associated with activation
of an oncogene SOX4 (a member of the SRY-related HMG-box) in esophageal carcinoma. …
of an oncogene SOX4 (a member of the SRY-related HMG-box) in esophageal carcinoma. …
Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study
R Wang, F Wu, H Lu, B Wei, G Feng, G Li, M Liu… - Journal of cancer …, 2013 - Springer
… In a pilot study conducted by Wang et al. (Wang et al. 2012), 138 NPC patients underwent
IMRT, 81.9 % of whom had stage III–IVb disease. There were 26 distant … Rensheng Wang …
IMRT, 81.9 % of whom had stage III–IVb disease. There were 26 distant … Rensheng Wang …
[HTML][HTML] Failure patterns of recurrence and metastasis after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma: results of a multicentric …
…, M Xu, Y Bin, P Zhou, Z Yang, K Liu, R Wang… - Frontiers in …, 2022 - frontiersin.org
Purpose This study aimed to explore factors associated with recurrence and metastasis
after intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC) …
after intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC) …
The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53
S Xiao, R Wang, X Wu, W Liu, S Ma - DNA and cell biology, 2018 - liebertpub.com
P73 antisense RNA 1T (non-protein coding), known as TP73-AS1 or PDAM, is a long
noncoding RNA (lncRNA), which may regulate apoptosis by regulation of p53-dependent …
noncoding RNA (lncRNA), which may regulate apoptosis by regulation of p53-dependent …